Antiphospholipidic Antibodies in SARS-CoV2 Infection: Still a Lot to Learn
und | 13. März 2021
Über diesen Artikel
Online veröffentlicht: 13. März 2021
Seitenbereich: 7 - 9
DOI: https://doi.org/10.2478/inmed-2021-0146
© 2021 Ciprian Jurcuţ et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Ciprian Jurcuţ
“Dr. Carol Davila” Central University Emergency Military Hospital,
Bucharest, Romania
Savino Sciascia
Nephrology and Dialysis Universitary Unit, and Center of Research of Immunopathology and Rare Diseases (CMID) San Giovanni Bosco Hospital,
and Department of Clinical and Biological Sciences, University of TurinTurin, Italy